EVALUATING THE ROLE OF THE MDCT IN DETECTION OF THE RENAL MASSES IN CANCER INSTITUTE

Abstract

Background: Due to advancements in diagnostic parameters, CT scan times have significantly decreased. This is because different software packages allow for adjustment of the scan settings and an increase in spatial resolution.  Aim: The purpose of this study was to examine the pattern of renal mass enhancement and attenuation at various stages (cortico-medullary, nephrographic, and unenhanced phases). 

Methods: Multidetector CT was utilized for a more accurate assessment of the enhancement pattern and attenuation values of renal masses during the nephrographic, corticomedullary, and unenhanced phases. Referrals for CT abdomen were made for participants who complained of flank pain/fullness, hematuria, or renal masses on ultrasonography. Finally, 20 cases with renal masses on CT that were confirmed to exist were added. 

Results: The kidney masses were determined to have a mean size of 6.4 ± 4 cm, with a range of 2 to 20 cm. 12 lesions were discovered to be cancerous, while eight lesions were benign. Only one benign lesion had poorly defined tumor margins, compared to seven benign lesions with well-defined margins. Merely two malignant lesions exhibited clearly defined margins, whereas the remaining ten lesions displayed poorly defined margins. There was a statistically significant difference between the margins of the benign and malignant tumours. In benign lesions, the enhancing pattern was diverse in three cases and homogenous in five. 

Conclusion: According to the current study's findings, renal masses should be appropriately characterized and detected during all phases of the examination process, including the nephrographic, corticomedullary, and enhanced phases.